오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - nevirapine, quantity: 200 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; microcrystalline cellulose; lactose monohydrate; colloidal anhydrous silica; sodium starch glycollate type a - nevirapine in combination with antiretroviral agents is indicated for the treatment of hiv-1 infection in adults and adolescents over the age of 16 years.,resistant virus emerges rapidly when nevirapine is administered as monotherapy or in dual combination therapy with an antiretroviral agent. therefore, nevirapine should always be administered in combination with at least two additional antiretroviral agents.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - nevirapine, quantity: 200 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; magnesium stearate; povidone; sodium starch glycollate type a - nevirapine in combination with antiretroviral agents is indicated for the treatment of hiv-1 infection in adults and adolescents over the age of 16 years.,resistant virus emerges rapidly when nevirapine is administered as monotherapy or in dual combination therapy with an antiretroviral agent. therefore, nevirapine should always be administered in combination with at least two additional antiretroviral agents.

나미비아 - 영어 - Namibia Medicines Regulatory Council

pharmacare limited - nevirapine - suspension - each 5,0ml suspension contains nevirapine hemihydrate equiv. to nevirapine 50,0 mg

말레이시아 - 영어 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - nevirapine hemihydrate -

말레이시아 - 영어 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - nevirapine -

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - nevirapine hemihydrate 10.35 mg/ml equivalent 10 mg/ml nevirapine;   - oral suspension - 10 mg/ml - active: nevirapine hemihydrate 10.35 mg/ml equivalent 10 mg/ml nevirapine   excipient: carbomer methyl hydroxybenzoate polysorbate 80 propyl hydroxybenzoate purified water sodium hydroxide sorbitol as 231.3 mg/ml sorbitol 70% solution sucrose - viramune is indicated for use in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and children over the age of 2 months.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - nevirapine 200mg - tablet - 200 mg - active: nevirapine 200mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified water sodium starch glycolate - viramune is indicated for use in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and children over the age of 2 months.

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - nevirapine anhydrate - eq. nevirapine 200 mg - tablet - 200 mg - nevirapine anhydrate - nevirapine

나미비아 - 영어 - Namibia Medicines Regulatory Council

macleods pharmaceuticals limited - nevirapine - tablet - each tablet contains, nevirapine 200,0 mg

나미비아 - 영어 - Namibia Medicines Regulatory Council

strides arcolab limited - nevirapine - tablet - each uncoated tablet contains; nevirapine 200,0 mg